WuXi Biologics (Cayman) Inc
HKEX:2269
WuXi Biologics (Cayman) Inc
HKEX:2269
Price:
31.82
HKD
-3.98%
Market Closed
Market Cap:
HK$131.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
CN |
|
Deep Polymers Ltd
BSE:541778
|
IN |
|
Hongli Zhihui Group Co Ltd
SZSE:300219
|
CN |
|
E
|
Esso Thailand PCL
SET:ESSO
|
TH |
|
F
|
Feerum SA
WSE:FEE
|
PL |
|
O
|
Orezone Gold Corp
TSX:ORE
|
CA |
|
Z
|
Zen Technologies Ltd
NSE:ZENTEC
|
IN |
|
W
|
Wulff Yhtiot Oyj
OMXH:WUF1V
|
FI |
|
Sleep Country Canada Holdings Inc
TSX:ZZZ
|
CA |
|
B
|
Bestlink Technologies Co Ltd
SSE:603206
|
CN |
|
Serial Achieva Ltd
SGX:XHV
|
MY |
Multiples-Based Value
The Multiples-Based Value of one
WuXi Biologics (Cayman) Inc
stock under the Base Case scenario is
hidden
HKD.
Compared to the current market price of 31.82 HKD,
WuXi Biologics (Cayman) Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
WuXi Biologics (Cayman) Inc Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
WuXi Biologics (Cayman) Inc Competitors
WuXi Biologics (Cayman) Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
134.8B HKD | 5.7 | 27.1 | 18.6 | 18.6 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
967B USD | 338.6 | 4 009 | 1 148.8 | 2 212.1 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
184.6B USD | 4.1 | 27.5 | 19.1 | 25.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
132.3B USD | 5.4 | 36.8 | 18.8 | 27.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.3B CHF | 5.2 | 36 | 26.8 | 26.8 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
268.9B CNY | 6.1 | 17.9 | 18 | 18 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.9B USD | 4.5 | 24.9 | 18.3 | 21.7 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.7B USD | 9.4 | 46.2 | 29.8 | 37.5 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.1B USD | 1.8 | 21.1 | 11.8 | 17.7 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.8B USD | 6.4 | 29.6 | 22 | 24.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
